期刊文献+

罗哌卡因预处理对其诱导ND7/23细胞毒性的影响 被引量:2

Effect of ropivacaine preconditioning on toxicity of ropivacaine to ND7/23 cells
原文传递
导出
摘要 目的评价罗哌卡因预处理对其诱导ND7/23细胞毒性的影响。方法正常培养ND7/23细胞,选择指数生长期的细胞,将其接种于96孔板上继续培养24h,浓度为1×10^6个/ml。采用随机数字表法,将细胞随机分为3组,每组3孔:对照组(C组)不给予任何处理;罗哌卡因组(R组)加入1%罗哌卡因100μl作用1h;罗哌卡因预处理组(RP组)先加入0.02%罗哌卡因100μl作用15min,洗脱后,再加入1%罗哌卡因100μl作用1h。采用CCK-8染色法检测细胞活力,采用Armexin-V/PI法检测细胞凋亡。结果与C组比较,R组和RP组细胞活力降低,早期凋亡率和晚期凋亡率升高(P〈0.05);与R组比较,RP组细胞活力升高,早期凋亡率和晚期凋亡率降低(P〈0.05)。结论罗哌卡因预处理可通过抑制细胞凋亡减轻其对ND7/23细胞的毒性作用。 Objective To investigate the effect of ropivacaine preconditioning on the toxicity of ropivacaine to ND7/23 cells. Methods ND7/23 cells were cultured in DMEM culture medium at 37 ℃ in 5 % CO2 incubator for 24 h at a concentration of 1 × 10^6/ml. The ceils were randomly divided into 3 groups ( n = 3 each) : control group (group C), repivacaine group (group R) and ropivacaine preconditioning group (group RP). In group R, the cells were exposed to 1% ropivacaine 100 μl and incubated for 1 h. In group RP, the cells were exposed to 0.02% repivacaine 100μl for 15 min, after repivacaine was washed out, 1% ropivacaine 100μl was then added and the cells were incubated for 1 h. The cell viability was measured using CCK-8 assay and apoptosis using Annexin-V/PI staining. Results Compared with group C, the cell viability was significantly decreased, while the early .apoptotic rate and late apoptotic rate were significantly increased in groups R and RP (P 〈 0.05). Compared with group R, the cell viability was significantly increased, while the early apoptotic rate and late apoptotic rate were significantly decreased in group RP ( P 〈 0.05). Conclusion Ropivacaine preconditioning can protect NDT/ 23 cells from bupivacaine-induced cytotoxicity through inhibiting apoptosis.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2011年第4期463-464,共2页 Chinese Journal of Anesthesiology
关键词 酰胺类 缺血预处理 药物毒性 Amides Ischemic preconditioning Drug toxicity
  • 相关文献

参考文献7

  • 1Mizutani K,Oda Y,Sato H.Successful treatment of ropivacaine-induced central nervous system toxicity by use of lipid emulsion:effect on total and unbound plasma fractions.J Anesth,2011,25(3):442-445.
  • 2Maher AJ,Metcalfe SA,Parr S.Local anaesthetic toxicity.Foot (Edinb),2008,18 (4):192-197.
  • 3Dunn PM,Coote PR,Wood JN,et al.Bradykinin evoked depolarization of a novel neuroblastoma x DRC neurone hybrid cell line (ND7/23).Brain Res,1991,545(1-2):80-86.
  • 4Kawano T,Oshita S,Takahashi A,et al.Molecular mechanisms of the inhibitory effects of bupivacaine,levobupivacaine,and ropivacaine on sarcolemmal adenosine triphosphate-sensitive potassium channels in the cardiovascular system.Anesthesiology,2004,101(2):390-398.
  • 5郭艳辉,王俊科,许国忠,虞建刚.罗哌卡因用于蛛网膜下腔阻滞的实验研究[J].中华麻醉学杂志,2002,22(1):42-45. 被引量:155
  • 6Mathewa J,Galameau L,Loranger A,et al.Keratin-protein Idnase C interaction in reactive oxygen species-induced hepatic cell death through mitochondrial signaling.Free Radic Biol Hed,2008,45(4):413-424.
  • 7Barua A,Standen NB,Galinanes M.Dual role of nNOS in ischemic injury and preconditioning.BMC Physiol,2010,10:15.

二级参考文献12

  • 1Svensson LG, Klepp P, Hinder RA. Spinal cord anatomy of the baboon: comparison with man and implications of spinal cord blood flow during thoracic aortic cross-clamping, A Aft J Surg, 1986, 24:32-34.
  • 2Krause GS, White BC, Aust SD, et al. Brain cell death following ischmia and reperfusion: a proposed biochemical sequence. Crit Care Med, 1988,16:714-726.
  • 3Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates on spinal cord function after temporary thoracic aortic occlusion. J Neurosci, 1984, 4:1884-1891.
  • 4Coombs DW. Management of chronic pain by epidural and intrathecal opioids: Newer drugs and delivery systems. Int Anesthesiol Clin, 1983, 24:59-74.
  • 5Auld AW, Maki-Jokela A, Murdoch DM. Intraspinal narcotic analgesia in the treatment of chronic pain. Spine, 1985, 10: 777-781.
  • 6Ishizake M, Sugiyama S, Uehida H, et al. Intrathecal oxygen concentration as a new indicator of spinal cord ischemia. Acta Med Okeyama 1997, 51: 71-77.
  • 7Kroin JS, McCarthy, Kerns JM, et al. The effect of chronic subarachnoid bupivacaine infusion in dogs. Anesthesiology, 1987,66: 737-742.
  • 8Grosby G. Local spinal cord blood flow and glucose utilization during spinal anesthesia with bupivacaine infusion in dogs. Anesthesiology,1987, 63: 55-60.
  • 9Kristensen JD. Spinal cord blood flow after intrathecal injection of ropivacaine: a screening for neurotoxic effects. Anesth Analg,1996, 82:636-640.
  • 10Iida H, Ohata H, Iida M. Attenuated additional hypocapnic constriction, but not hypercapnic dilation, of spinal pial arterioles during spinal ropivacaine. Anesth Analg, 1999, 89:1510-1513.

共引文献154

同被引文献22

  • 1Yu J, Wei'wer M, Linhardt R J, et al. The role of the methoxyphenol apocynin, a vascular NADPH oxidase inhibitor, as a chemopreventative agent in the potential treatment of cardiovascular diseases. Curr Vasc Pharmacol, 2008, 6: 204-217.
  • 2Tsutsui H, Kinugawa S, Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc res, 2009, 81: 449-456.
  • 3Youu JY, Zhang J, Zhang Y, et al. Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol, 2013, 62: 72-79.
  • 4Erickson JR, He BJ, Grumbach IM, et al. CaMK 11 in the cardiovascular system: sensing redox states. Physiol rev, 2011, 91: 889-915.
  • 5Li H, Xia N, Ffirstermann U. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide, 2012, 26:102-110.
  • 6Baczko I, Liknes D, Yang W, et al. Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation. Br J Pharmacol, 2014, 171: 92-106.
  • 7He T, Guan X, Wang S, et al. Resveratrol prevents high glucose- induced epithelial-mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway. Mol Cell Endocrinnl, 2015, 402:13-20.
  • 8Rosenbaugh EG, Savalia KK, Manickam DS, et al. Antioxidant-based therapies for angiotensln 11 -associated cardiovascular diseases. Am J Physiol-Regul Integr Com Physiol, 2013, 304: R917-R928.
  • 9Swaminathan PD, Purohit A, Hund TJ, et al. Calmodulin-dependent protein kinase II : linking heart failure and arrhythmlas. Cir Res, 2012, 110: 1661-1677.
  • 10Purohit A, Rokita AG, Guan X, et al. Oxidized Ca2+/calmodulin- dependent protein kinase I1 triggers atrial fibrillation. Circulation, 2013, 128: 1748-1757.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部